Cargando…
NOX1 inhibition attenuates the development of a pro‐tumorigenic environment in experimental hepatocellular carcinoma
BACKGROUND: The poor prognosis of advanced HCC and limited efficacy of current systemic treatments emphasize the need for new or combined targeted therapies. The development of HCC is a multistage process in which liver injury appears in a complex microenvironment associated with oxidative stress. N...
Autores principales: | Vandierendonck, Astrid, Degroote, Helena, Vanderborght, Bart, Verhelst, Xavier, Geerts, Anja, Devisscher, Lindsey, Van Vlierberghe, Hans |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7824948/ https://www.ncbi.nlm.nih.gov/pubmed/33485364 http://dx.doi.org/10.1186/s13046-021-01837-6 |
Ejemplares similares
-
Characterization of the inflammatory microenvironment and hepatic macrophage subsets in experimental hepatocellular carcinoma models
por: Degroote, Helena, et al.
Publicado: (2021) -
Effect of isoform-specific HIF-1α and HIF-2α antisense oligonucleotides on tumorigenesis, inflammation and fibrosis in a hepatocellular carcinoma mouse model
por: Vanderborght, Bart, et al.
Publicado: (2020) -
Different Models to Predict the Risk of Recurrent Hepatocellular Carcinoma in the Setting of Liver Transplantation
por: Degroote, Helena, et al.
Publicado: (2022) -
The Angiopoietin/Tie2 Pathway in Hepatocellular Carcinoma
por: Vanderborght, Bart, et al.
Publicado: (2020) -
Next-generation proteasome inhibitor oprozomib synergizes with modulators of the unfolded protein response to suppress hepatocellular carcinoma
por: Vandewynckel, Yves-Paul, et al.
Publicado: (2016)